Dicerna Pharmaceuticals reported $772.06M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Biogen BIIB:US $ 23806.7M 663.7M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Exelixis EXEL:US $ 2447.74M 80.47M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Immunogen IMGN:US $ 296.8M 4.64M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
Intrexon XON:US $ 376.9M 25.67M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Lexicon Pharmaceuticals LXRX:US $ 172.33M 658K
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M